Download Action Plan - Australian Packaging Covenant

1. Company Profile
1.1. Background
We are Australia’s chosen national plasma fractionator and, under contract to
Australia’s National Blood Authority, manufacture a complete range of life saving
plasma-derived therapies for the treatment of the Australian community. The
range of plasma-derived therapies we manufacture for Australia is the largest
manufactured in a single facility globally. It is also the only range in which every
product is manufactured using processes that include at least two dedicated and
complementary pathogen reduction steps. We are also the chosen national
plasma fractionator of New Zealand, Hong Kong, Malaysia, Singapore and
Taiwan.
We also manufacture a range of immunohaematology products (diagnostic
reagents) that are supplied to Australian laboratories to enhance the safety of
blood transfusions for patients in Australia.
We also operate one of the world’s largest influenza vaccine manufacturing
facilities and supply seasonal influenza vaccines to Australia and global markets.
Working closely with public health authorities and the Australian Department of
Health & Ageing we have used our influenza vaccine technology to develop and
license a safe and effective pandemic influenza vaccine providing biosecurity to
Australia’s population in the event of an influenza pandemic such as the 2009
swine flu. We are Australia’s first line of defence against pandemic influenza.
1.2. Environment
Our commitment to the environment is set by the Board and articulated in our
Code of Responsible Business Practice. Executive management teams and the
Audit and Risk Management Committee of the CSL Board monitor
environmental performance.
Business unit leaders ensure all sites work within CSL’s global environmental
framework. Our Global Environment Policy provides further guidance to
management and staff. HSE staff at each site collaborates with functional groups
to manage and improve environmental performance relative to local impacts.
We continue to report on various regulatory and voluntary programs which are
also supported by internal targets which have been established to minimise the
environmental impacts of our operations. Additional information on our
environmental performance can be found on our website www.csl.com.au.
3